ArticlebioRxiv : the preprint server for biology2026

BTK inhibition enhances immunovirotherapy in glioblastoma via tertiary lymphoid structure modulation.

Konstantina Kyritsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.